{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:27:07Z","timestamp":1764937627773},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,22]]},"DOI":"10.7759\/cureus.47460","type":"journal-article","created":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T13:18:10Z","timestamp":1697980690000},"source":"Crossref","is-referenced-by-count":2,"title":["A Study on Renal Failure Management in Patients Diagnosed With Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Lama M","family":"Almuhaysen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Badr Abu Al","family":"Alaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo A","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011, 364:1046-60. 10.1056\/NEJMra1011442","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2205","article-title":"Improved survival of older patients with multiple myeloma in the era of novel agents","volume":"34","author":"Mey UJ","year":"2016","unstructured":"Mey UJ, Leitner C, Driessen C, Cathomas R, Klingbiel D, Hitz F. Improved survival of older patients with multiple myeloma in the era of novel agents. Hematol Oncol. 2016, 34:217-23. 10.1002\/hon.2205","journal-title":"Hematol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_62_18","article-title":"Multiple myeloma in Saudi Arabia: consensus of the Saudi lymphoma\/myeloma group","volume":"10","author":"Alaskar A","year":"2019","unstructured":"Alaskar A, Alsaeed A, Alsharif FZ, Alhashmi H, Alghamdi M. Multiple myeloma in Saudi Arabia: consensus of the Saudi lymphoma\/myeloma group. J Appl Hematol. 2019, 10:37-44. 10.4103\/joah.joah_62_18","journal-title":"J Appl Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2011.11928744","article-title":"Multiple myeloma presenting as acute renal failure","volume":"24","author":"Kuo VC","year":"2011","unstructured":"Kuo VC, Fenves AZ, Mehta AN. Multiple myeloma presenting as acute renal failure. Proc (Bayl Univ Med Cent). 2011, 24:302-5. 10.1080\/08998280.2011.11928744","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2021.198","article-title":"Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia","volume":"41","author":"Abdrabou AK","year":"2021","unstructured":"Abdrabou AK, Sharif FA, Fakih RE, et al.. Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia. Ann Saudi Med. 2021, 41:198-205. 10.5144\/0256-4947.2021.198","journal-title":"Ann Saudi Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.92","article-title":"Interpretation of cytogenetic results in multiple myeloma for clinical practice","volume":"5","author":"Rajan AM","year":"2015","unstructured":"Rajan AM, Rajkumar SV. Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer J. 2015, 5:e365. 10.1038\/bcj.2015.92","journal-title":"Blood Cancer J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.108","article-title":"Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains","volume":"73","author":"Leung N","year":"2008","unstructured":"Leung N, Gertz MA, Zeldenrust SR, et al.. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int. 2008, 73:1282-8. 10.1038\/ki.2008.108","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59071326","article-title":"Multiple myeloma and kidney impairment at diagnosis: a nephrological perspective from an Eastern European country","volume":"59","author":"\u0218tefan G","year":"2023","unstructured":"\u0218tefan G, Cinca S, Chiriac C, Zugravu A, Stancu S. Multiple myeloma and kidney impairment at diagnosis: a nephrological perspective from an Eastern European country. Medicina (Kaunas). 2023, 59:1326. 10.3390\/medicina59071326","journal-title":"Medicina (Kaunas)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.01.013","article-title":"Renal, hematologic and infectious complications in multiple myeloma","volume":"18","author":"Blad\u00e9 J","year":"2005","unstructured":"Blad\u00e9 J, Rosi\u00f1ol L. Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol. 2005, 18:635-52. 10.1016\/j.beha.2005.01.013","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma","volume":"335","author":"Attal M","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, et al.. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996, 335:91-7. 10.1056\/NEJM199607113350204","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030415","article-title":"Past, present, and a glance into the future of multiple myeloma treatment","volume":"16","author":"Elbezanti WO","year":"2023","unstructured":"Elbezanti WO, Challagundla KB, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK. Past, present, and a glance into the future of multiple myeloma treatment. Pharmaceuticals (Basel). 2023, 16:415. 10.3390\/ph16030415","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009138","article-title":"Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis","volume":"7","author":"Ragon BK","year":"2023","unstructured":"Ragon BK, Shah MV, D'Souza A, et al.. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023, 7:2746-57. 10.1182\/bloodadvances.2022009138","journal-title":"Blood Adv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010051","article-title":"Autologous transplant and second malignancies in MM","volume":"7","author":"Pasvolsky O","year":"2023","unstructured":"Pasvolsky O, Bashir Q. Autologous transplant and second malignancies in MM. Blood Adv. 2023, 7:2731-2. 10.1182\/bloodadvances.2023010051","journal-title":"Blood Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.6679","article-title":"Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis","volume":"35","author":"McCarthy PL","year":"2017","unstructured":"McCarthy PL, Holstein SA, Petrucci MT, et al.. Lenalidomide maintenance after autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis. J Clin Oncol. 2017, 35:3279-89. 10.1200\/JCO.2017.72.6679","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.134049","article-title":"Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study","volume":"101","author":"Jonsdottir G","year":"2016","unstructured":"Jonsdottir G, Lund SH, Bj\u00f6rkholm M, et al.. Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study. Haematologica. 2016, 101:e145-8. 10.3324\/haematol.2015.134049","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194919","article-title":"Second primary malignancy risk in multiple myeloma from 1975 to 2018","volume":"14","author":"Wang J","year":"2022","unstructured":"Wang J, Lv C, Zhou M, Xu JY, Chen B, Wan Y. Second primary malignancy risk in multiple myeloma from 1975 to 2018. Cancers (Basel). 2022, 14:4919. 10.3390\/cancers14194919","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.295","article-title":"Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology","volume":"2010","author":"Landgren O","year":"2010","unstructured":"Landgren O. Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology. Hematology Am Soc Hematol Educ Program. 2010, 2010:295-302. 10.1182\/asheducation-2010.1.295","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle RA","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008, 111:2962-72. 10.1182\/blood-2007-10-078022","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp PR","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, et al.. International staging system for multiple myeloma. J Clin Oncol. 2005, 23:3412-20. 10.1200\/JCO.2005.04.242","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.168","article-title":"The pathogenesis and diagnosis of acute kidney injury in multiple myeloma","volume":"8","author":"Hutchison CA","year":"2012","unstructured":"Hutchison CA, Batuman V, Behrens J, et al.. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol. 2012, 8:43-51. 10.1038\/nrneph.2011.168","journal-title":"Nat Rev Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar SK","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, et al.. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014, 28:1122-8. 10.1038\/leu.2013.313","journal-title":"Leukemia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.8791","article-title":"Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group","volume":"28","author":"Dimopoulos MA","year":"2010","unstructured":"Dimopoulos MA, Terpos E, Chanan-Khan A, et al.. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol. 2010, 28:4976-84. 10.1200\/JCO.2010.30.8791","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0037-4","article-title":"Pathogenesis of bone disease in multiple myeloma: from bench to bedside","volume":"8","author":"Terpos E","year":"2018","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, Dimopoulos MA. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018, 8:7. 10.1038\/s41408-017-0037-4","journal-title":"Blood Cancer J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.9.3163","article-title":"Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients","volume":"99","author":"Berenson JR","year":"2002","unstructured":"Berenson JR, Crowley JJ, Grogan TM, et al.. Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients. Blood. 2002, 99:3163-8. 10.1182\/blood.v99.9.3163","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150:604-12. 10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.63","article-title":"Treatment of multiple myeloma","volume":"8","author":"Rajkumar SV","year":"2011","unstructured":"Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 2011, 8:479-91. 10.1038\/nrclinonc.2011.63","journal-title":"Nat Rev Clin Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.131","article-title":"Pathogenesis and treatment of renal failure in multiple myeloma","volume":"22","author":"Dimopoulos MA","year":"2008","unstructured":"Dimopoulos MA, Kastritis E, Rosinol L, Blad\u00e9 J, Ludwig H. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia. 2008, 22:1485-93. 10.1038\/leu.2008.131","journal-title":"Leukemia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1024133","article-title":"High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury","volume":"12","author":"Xing Y","year":"2022","unstructured":"Xing Y, Yan J, Yu Z, et al.. High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury. Front Oncol. 2022, 12:1024133. 10.3389\/fonc.2022.1024133","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22585","article-title":"Multiple myeloma and renal failure: mechanisms, diagnosis, and management","volume":"14","author":"Kundu S","year":"2022","unstructured":"Kundu S, Jha SB, Rivera AP, et al.. Multiple myeloma and renal failure: mechanisms, diagnosis, and management. Cureus. 2022, 14:e22585. 10.7759\/cureus.22585","journal-title":"Cureus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000442511","article-title":"Current trends of renal impairment in multiple myeloma","volume":"1","author":"Yadav P","year":"2016","unstructured":"Yadav P, Cook M, Cockwell P. Current trends of renal impairment in multiple myeloma. Kidney Dis (Basel). 2016, 1:241-57. 10.1159\/000442511","journal-title":"Kidney Dis (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/182236-a-study-on-renal-failure-management-in-patients-diagnosed-with-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:53Z","timestamp":1707509513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/182236-a-study-on-renal-failure-management-in-patients-diagnosed-with-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,22]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.47460","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,22]]}}}